| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Aspergillosis | D001228 | 5 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Berger J et al. | Evidence for basolateral Cl- channels as modulators of apical Cl- secretion in pulmonary epithelia of Xenopus laevis. | 2011 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:21123756 |
| Day TP et al. | Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin. | 2011 | Mol. Pharm. | pmid:21141891 |
| El-Ridy MS et al. | Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. | 2011 | Drug Dev Ind Pharm | pmid:21707323 |
| Zerbib C et al. | One-pot synthesis of a new antifungal polymerisable monomer and its characterisation by coordination-ion spray mass spectrometry. | 2011 | Rapid Commun. Mass Spectrom. | pmid:21710593 |
| Kodedová M et al. | Fluorescence method for determining the mechanism and speed of action of surface-active drugs on yeast cells. | 2011 | BioTechniques | pmid:21231924 |
| Stewart AK et al. | Functional characterization and modified rescue of novel AE1 mutation R730C associated with overhydrated cation leak stomatocytosis. | 2011 | Am. J. Physiol., Cell Physiol. | pmid:21209359 |
| Messier C and Grenier D | Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. | 2011 | Mycoses | pmid:21615543 |
| Mayercik VA et al. | Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids. | 2011 | Arch. Ophthalmol. | pmid:21746988 |
| Pendela M et al. | Simultaneous determination of lidocaine hydrochloride, hydrocortisone and nystatin in a pharmaceutical preparation by RP-LC. | 2011 | J Pharm Biomed Anal | pmid:21794999 |
| Yamasaki M et al. | Effects and mechanisms of action of polyene macrolide antibiotic nystatin on Babesia gibsoni in vitro. | 2011 | J. Parasitol. | pmid:21756054 |
| Valitova JN et al. | Effects of sterol-binding agent nystatin on wheat roots: the changes in membrane permeability, sterols and glycoceramides. | 2011 | Phytochemistry | pmid:21726881 |
| Ebert S et al. | Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis. | 2011 | Z Gerontol Geriatr | pmid:21732154 |
| Sakeer K et al. | Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. | 2010 Jul-Aug | Pharm Dev Technol | pmid:19772376 |
| Peacock G et al. | Accuracy and precision of manufacturer-supplied liquid medication administration devices before and after patient education. | 2010 Jan-Feb | J Am Pharm Assoc (2003) | pmid:20097644 |
| Sakeer K et al. | Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation. | 2010 | Arch. Pharm. Res. | pmid:21116780 |
| Ogita A et al. | Targeted yeast vacuole disruption by polyene antibiotics with a macrocyclic lactone ring. | 2010 | Int. J. Antimicrob. Agents | pmid:19910165 |
| de Aguiar MM et al. | Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. | 2010 | Drug Dev Ind Pharm | pmid:19954405 |
| Preobrazhenskaya MN et al. | Synthesis and study of the antifungal activity of new mono- and disubstituted derivatives of a genetically engineered polyene antibiotic 28,29-didehydronystatin A1 (S44HP). | 2010 | J. Antibiot. | pmid:19960041 |
| BÃlková E et al. | Targeted antifungal delivery system: beta-glucosidase sensitive nystatin-star poly(ethylene glycol) conjugate. | 2010 | Int J Pharm | pmid:19874880 |
| Young JP et al. | Acetylsalicylic acid enhances purinergic receptor-mediated outward currents in rat megakaryocytes. | 2010 | Am. J. Physiol., Cell Physiol. | pmid:20042731 |